Breast cancer exosome protein expression levels of Mortalin and Vimentin mirrored the effects observed in the parental breast cancer cells treated with SMRwt, miR-Vimentin, and miR-Mortalin (Fig. 6C,D). The gene discussed is HSPA9; the disease is breast carcinoma.